NEW YORK and TOKYO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) ("HeartCore" or "the Company"), a leading enterprise software and data consulting services company based in Tokyo, announced its Content Management System ("CMS") platform has achieved top market share in sales value in Japan for nine consecutive years, according to ITR Corporation, an independent IT consulting and research firm. The report disclosed that HeartCore owns a leading 15.1% market share in Japan, wit ...

Designed to help dialysis organizations incorporate new treatments into their practices, TDAPA provides two years of reimbursement in addition to the ESRD bundled rate A HCPCS code has also been assigned to Vafseo to facilitate reimbursement at dialysis organizations CAMBRIDGE, Mass., Oct. 10, 2024 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that the Center for Medicare & Med ...

NEW YORK and TOKYO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) ("HeartCore" or "the Company"), a leading enterprise software and data consulting services company based in Tokyo, announced it has been awarded a new contract from Fourmix Co., Ltd. ("Fourmix"), a Japanese IT and web development company. Partnership Logo Through this contract, HeartCore will implement its CMS platform to enhance Fourmix's web development and digital marketing domain capabilities. HeartCore will ...

CMS Energy Corporation (CMS) is making systematic investments to enhance its operations and gain from delivering high-quality services to its consumers. The company is expanding its renewable power portfolio while eliminating coal-generating units. However, this Zacks Rank #3 (Hold) company is exposed to unfavorable costs associated with the shutdown of solid waste disposal facilities for coal ash and fluctuating commodity prices, which are headwinds. Factors Acting in Favor of CMS CMS Energy is investing h ...

TI AND FOR 1 11:10 THE HD imantsu With the recent rise in the utility segment valuations as investors prepare for the strong potential of lower competitive interest rates, CMS Energy Co (NYSE:CMS) stock price has been strong. This has led to an overabundance of "Hold" recommendations for CMS stock. However, for long-term investors, CMS should be viewed as a highquality selection, both in earnings and dividend production and, more importantly, in its supportive regulatory background. I do not own the common ...

Core Insights - Abeona Therapeutics announced that the Centers for Medicare and Medicaid Services (CMS) has granted a product-specific procedure code ICD-10-PCS for prademagene zamikeracel (pz-cel), an investigational gene therapy for recessive dystrophic epidermolysis bullosa (RDEB) [1] - CMS assigned Medicare reimbursement for pz-cel to Pre-Major Diagnostic Category, Medicare Severity Diagnosis Related Group 018, which is among the highest reimbursement levels for cell and gene therapies, effective October 1, 2024 [2] - The Chief Commercial Officer of Abeona expressed confidence in securing access and reimbursement for RDEB patients following favorable Medicare decisions and positive feedback from commercial payers [3] Product Overview - Prademagene zamikeracel (pz-cel) is an autologous cell-based gene therapy designed to treat RDEB, a rare connective tissue disorder caused by a defect in the COL7A1 gene [4] - Pz-cel aims to incorporate the functional COL7A1 gene into a patient's skin cells, enabling long-term gene expression and facilitating wound healing [4] - The pivotal Phase 3 VIITAL™ study evaluated pz-cel's efficacy, safety, and tolerability in 43 large chronic wound pairs among 11 subjects with RDEB [4] Company Background - Abeona Therapeutics is a clinical-stage biopharmaceutical company focused on developing cell and gene therapies for serious diseases [5] - The company operates a fully integrated cGMP manufacturing facility in Cleveland, Ohio, which supports the production of pz-cel for clinical trials and potential commercial use [5] - Abeona's development portfolio includes AAV-based gene therapies for ophthalmic diseases, utilizing next-generation AAV capsids to improve treatment efficacy [5]

Multiple AI-powered features and seamless CMS integration influence Sitefinity Insight's status as a RealCDP™ BURLINGTON, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Progress (Nasdaq: PRGS), the trusted provider of AI-powered infrastructure software, today announced that Progress® Sitefinity Insight® customer data platform (CDP) has been certified by the Customer Data Platform (CDP) Institute as a RealCDP™ for meeting specific standards and capabilities that are essential for managing and utilizing customer da ...

NorthStar Clean Energy and General Motors launch Newport Solar to help power GM facilities ANN ARBOR, Mich., Aug. 7, 2024 /PRNewswire/ -- NorthStar Clean Energy proudly announces the official opening of Newport Solar, a 180 MW project designed to source renewable electricity for General Motors' operations in the Midcontinent Independent System Operator (MISO) territory including Lansing Delta Township Assembly and Lansing Grand River Assembly in Michigan, as well as Wentzville Assembly in Missouri, which un ...

. ● . Therma Bright Receives Positive Notification from U.S. DHHS's Centers for Medicare & Medicaid (CMS) Company anticipates CMS permanent CPT(R) and HCPCS codes in the coming days August 01, 2024 7:13 AM EDT | Source: Therma Bright Inc. Toronto, Ontario--(Newsfile Corp. - August 1, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies, is pleased to provi ...

Financial Data and Key Metrics Changes - The company reported adjusted earnings per share of $1.63 for the first half of 2024, an increase of $0.18 compared to the same period in 2023, primarily driven by constructive outcomes in electric and gas rate cases [87][90] - Full year guidance remains at $3.29 to $3.35 per share, with confidence towards the high end of the range [87] - The company anticipates a positive variance of $0.20 per share for the remaining half of the year based on normal weather conditions [94] Business Line Data and Key Metrics Changes - The company experienced a slight decline in commercial and industrial weather-adjusted volumes, with commercial down about 1% and industrial down about 2% compared to the previous year [28][29] - Despite the decline, residential sales were slightly up by 0.1%, indicating mixed performance across customer classes [30] Market Data and Key Metrics Changes - There is strong interest in manufacturing and data centers in Michigan, with a notable 230-megawatt data center project moving forward regardless of legislative changes [6][21] - The company is seeing economic growth in Michigan, which is expected to positively impact its renewable energy plan [12][58] Company Strategy and Development Direction - The company emphasizes a commitment to affordable bills for customers while making significant investments in infrastructure, with a focus on renewable energy and energy waste reduction programs [80][84] - The regulatory environment in Michigan is described as strong and supportive, with mechanisms in place for financial recovery and energy efficiency incentives [79][81] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to deliver on financial objectives despite challenges such as adverse weather conditions and storm impacts [90][96] - The company is optimistic about the economic development activity in Michigan, which is expected to drive higher demand and necessitate additional renewable energy resources [58][66] Other Important Information - The company plans to issue approximately $675 million in debt in the second half of the year, an increase from the previously estimated $500 million, to rebalance its capital structure [97] - The performance-based ratemaking framework is still under constructive dialogue, with implementation expected to be several rate cases away [54][56] Q&A Session Summary Question: Thoughts on opportunity to service data centers and legislation impact - Management noted strong interest in data centers in Michigan, with ongoing projects not contingent on legislation [21] Question: Demand trends and CMS positioning for upside - Management indicated that additional upside is expected from the energy law and financial compensation mechanisms, with filings planned for 2026 [10][11] Question: Update on electric rate case and settlement opportunities - Management expressed confidence in the electric rate case, highlighting the complexity and the number of interested parties involved [14][15] Question: Commentary on C&I weather-adjusted volumes and near-term outlook - Management acknowledged a pullback in C&I volumes but emphasized that overall conditions remain favorable when adjusted for energy waste reduction [28][30] Question: Update on performance-based ratemaking - Management confirmed ongoing constructive dialogue regarding performance-based ratemaking metrics, with implementation expected in the next couple of years [54][56] Question: Trends in electric demand versus 2021 IRP - Management stated that electric demand is trending higher than the 2021 IRP, driven by economic development activity [58]